University of California San Francisco
Give to UCSF
Irregular heart impulses that lead to stroke can be detected using a smartwatch with a specially designed application, a finding that could eventually lead to new ways to screen patients for earlier treatment.
UCSF scientists have uncovered new mechanisms by which HIV hides in infected cells, resting in a latent state that evades the body’s immune system and preventing antiviral drugs from flushing it out.
Samsung Electronics Co., Ltd. and UCSF have announced the launch of My BP Lab, a jointly developed smartphone research app to help users monitor their blood pressure and stress levels.
A new UCSF study has shown that a cancer-killing (“oncolytic”) virus currently in clinical trials may function as a cancer vaccine.
Office visits offer doctors only a snapshot of chronic conditions. That’s where new mobile health-tracking technology can make a real difference, providing detailed and long-term health data for each patient.
More and more, the promise of EHRs transforming data into knowledge is beginning to bear fruit.
UCSF neurologists have discovered monthly cycles of brain activity linked to seizures in patients with epilepsy.
UCSF: The Campaign is taking on the world’s most complex health challenges, powered by an exceptional community of mavericks, innovators, and advocates. Together we will make the Bay Area and our world healthier for all.
UCSF physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia will respond to treatment.
Today’s lasers are fine-tuned instruments that can safely and painlessly remove cavities and prevent cavities before they start.
New research finds one of the world’s most deadly forms of lung cancer is driven by changes in multiple different genes.
Scientists from two U.S. national laboratories, industry, and academia on Oct. 27 launched an unprecedented effort to transform the way cancer drugs are discovered.
UCSF Health Informatics team has used electronic health records to track down a source of a common hospital-acquired infection.
Encellin obtained exclusive rights from UCSF for a proprietary cell encapsulation technology aimed at improving physicians’ ability to perform cell transplants without the need for immunosuppressive drugs.
U.S. hospitals are making slow progress in ensuring that their providers have access to and use patients’ complete electronic health records when those patients have also received care from outside providers.
